These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 7025157)
1. Chemistry and immunochemistry of the pneumococcal polysaccharide vaccine with special reference to cross-reactions and immunologic factors. Schiffman G Rev Infect Dis; 1981; 3 Suppl():S18-30. PubMed ID: 7025157 [TBL] [Abstract][Full Text] [Related]
2. First and second dose antibody responses to pneumococcal polysaccharide vaccine in infants. Koskela M; Leinonen M; Häivä VM; Timonen M; Mäkelä PH Pediatr Infect Dis; 1986; 5(1):45-50. PubMed ID: 3945575 [TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and efficacy of Streptococcus pneumoniae polysaccharide-protein conjugate vaccines against homologous and heterologous serotypes in the chinchilla otitis media model. Giebink GS; Meier JD; Quartey MK; Liebeler CL; Le CT J Infect Dis; 1996 Jan; 173(1):119-27. PubMed ID: 8537648 [TBL] [Abstract][Full Text] [Related]
4. Comparative immunogenicity of group 6 pneumococcal type 6A(6) and type 6B(26) capsular polysaccharides. Robbins JB; Lee CJ; Rastogi SC; Schiffman G; Henrichsen J Infect Immun; 1979 Dec; 26(3):1116-22. PubMed ID: 43290 [TBL] [Abstract][Full Text] [Related]
5. Antibody response to 14-valent pneumococcal capsular polysaccharide vaccine in pre-school age children. Leinonen M; Säkkinen A; Kalliokoski R; Luotonen J; Timonen M; Mäkelä PH Pediatr Infect Dis; 1986; 5(1):39-44. PubMed ID: 3945574 [TBL] [Abstract][Full Text] [Related]
6. Response to a heptavalent conjugate Streptococcus pneumoniae vaccine in children with recurrent infections who are unresponsive to the polysaccharide vaccine. Sorensen RU; Leiva LE; Giangrosso PA; Butler B; Javier FC; Sacerdote DM; Bradford N; Moore C Pediatr Infect Dis J; 1998 Aug; 17(8):685-91. PubMed ID: 9726341 [TBL] [Abstract][Full Text] [Related]
7. Pneumococcal antibody levels one decade after immunization of healthy adults. Mufson MA; Krause HE; Schiffman G; Hughey DF Am J Med Sci; 1987 May; 293(5):279-84. PubMed ID: 3591818 [TBL] [Abstract][Full Text] [Related]
8. Planning for a second (23 valent) generation pneumococcal vaccine. With special reference to new developments in our understanding of the structure and biology of polysaccharides. Robbins JB; Schneerson R Bull Eur Physiopathol Respir; 1983; 19(2):215-26. PubMed ID: 6347282 [TBL] [Abstract][Full Text] [Related]
9. Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta. Breukels MA; Rijkers GT; Voorhorst-Ogink MM; Zegers BJ; Sanders LA J Infect Dis; 1999 May; 179(5):1152-6. PubMed ID: 10191217 [TBL] [Abstract][Full Text] [Related]
10. Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. Robbins JB; Austrian R; Lee CJ; Rastogi SC; Schiffman G; Henrichsen J; Mäkelä PH; Broome CV; Facklam RR; Tiesjema RH J Infect Dis; 1983 Dec; 148(6):1136-59. PubMed ID: 6361173 [No Abstract] [Full Text] [Related]
11. Capsular types of Streptococcus pneumoniae isolated from blood and CSF during 1982-1987. Nielsen SV; Henrichsen J Clin Infect Dis; 1992 Nov; 15(5):794-8. PubMed ID: 1445978 [TBL] [Abstract][Full Text] [Related]
12. Cross-reactivity of antibodies to type 6B and 6A polysaccharides of Streptococcus pneumoniae, evoked by pneumococcal conjugate vaccines, in infants. Väkeväinen M; Eklund C; Eskola J; Käyhty H J Infect Dis; 2001 Sep; 184(6):789-93. PubMed ID: 11517443 [TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and reactogenicity of new multivalent pneumococcal vaccines. Wiedermann G; Jovanovic D; Georges AM; Hauser P; Ambrosch F Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Apr; 251(4):494-504. PubMed ID: 7201725 [TBL] [Abstract][Full Text] [Related]
14. Studies on vaccine control and immunogenicity of polysaccharides of Streptococcus pneumoniae. Lee CJ; Lin KT Rev Infect Dis; 1981; 3 Suppl():S51-60. PubMed ID: 6169130 [TBL] [Abstract][Full Text] [Related]
15. Bacterial capsular polysaccharides--biochemistry, immunity and vaccine. Lee CJ Mol Immunol; 1987 Oct; 24(10):1005-19. PubMed ID: 3119993 [TBL] [Abstract][Full Text] [Related]
16. Development and Validation of 13-plex Luminex-Based Assay for Measuring Human Serum Antibodies to Pavliakova D; Giardina PC; Moghazeh S; Sebastian S; Koster M; Pavliak V; McKeen A; French R; Jansen KU; Pride M mSphere; 2018 Aug; 3(4):. PubMed ID: 30089645 [TBL] [Abstract][Full Text] [Related]
17. Antibody responses in adult volunteers to pneumococcal polysaccharide types 19F and 19A administered singly and in combination. Penn RL; Lewin EB; Douglas RG; Schiffman G; Lee CJ; Robbins JB Infect Immun; 1982 Jun; 36(3):1261-2. PubMed ID: 7095850 [TBL] [Abstract][Full Text] [Related]
18. Immunochemical relations between pneumococcal group 19 and Klebsiella capsular polysaccharides. Lee CJ; Koizumi K J Immunol; 1981 Oct; 127(4):1619-23. PubMed ID: 6792279 [TBL] [Abstract][Full Text] [Related]